Washington University School of Medicine Plans BSL-3 Laboratory

Washington University School of Medicine will break ground in spring of 2022 on a $150 million vertical expansion of the Steven & Susan Lipstein BJC Institute of Health in St. Louis. Designed by Lawrence Group to promote collaboration and discovery, the six-story, 160,000-sf addition will provide 103,000 sf of biomedical research space and a 7,900-sf BSL-3 laboratory for the study of infectious diseases such as SARS-CoV-2 and tuberculosis. The 5,100-sf Biologic Therapy Core Facility will accommodate cGMP manufacturing operations for the creation of cellular cancer treatments. Alberici is the construction manager for the project, which will include 44,000 sf of mechanical and support space. Completion is expected in 2024.